UROLOGIX INC Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2015-07-10: Form 8-K; Period of report 2015-07-09; Description 2.02 Results of Operations and Financial Condition; 8.01 Other Events.
- 2015-05-13: Form 8-K; Period of report 2015-05-12; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2015-03-23: Form 8-K; Period of report 2015-03-17; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2015-02-06: Form 8-K; Period of report 2015-02-05; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2015-07-10 | 8-K | 2015-07-09 | 2.02 Results of Operations and Financial Condition; 8.01 Other Events | urologix152450_8k.htm | |
| 2015-05-13 | 8-K | 2015-05-12 | 2.02 Results of Operations and Financial Condition | 2.02 Urologix, Inc. (the “Company”) hereby furnishes as Exhibit 99.1 a press release issued on May 12, 2015 disclosing material non-public information regarding the Company’s results of operations for the third fiscal quarter of fiscal year 2015 ended March 31, 2015. | urologix151737_8k.htm |
| 2015-03-23 | 8-K | 2015-03-17 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 17, 2015, Urologix, Inc. (the “Company”) and Scott M. Madson entered into a letter agreement (the “offer letter”) pursuant to which Mr. Madson agreed to serve as the Company’s Chief Financial Officer effective as of April 1, 2015. | urologix151110_8k.htm |
| 2015-02-06 | 8-K | 2015-02-05 | 2.02 Results of Operations and Financial Condition | 2.02 Urologix, Inc. (the “Company”) hereby furnishes as Exhibit 99.1 a press release issued on February 5, 2015 disclosing material non-public information regarding the Company’s results of operations for the second fiscal quarter of fiscal year 2015 ended December 31, 2014. | urologix150439_8k.htm |
| 2015-01-12 | 8-K | 2015-01-12 | 2.02 Results of Operations and Financial Condition; 8.01 Other Events | 2.02 Urologix, Inc. (the “Company”) hereby furnishes a press release, issued on January 12, 2015, disclosing preliminary revenue results for quarter ended December 31, 2014 and preliminary cash balances at December 31, 2014. 8.01 The Company’s management may discuss the preliminary results for the quarter ended December 31, 2014 as disclosed in the press release furnished as Exhibit 99.1 in meetings with prospective strategic partners, investors, shareholders and others taking place around the J.P. Morgan 33rd Annual Healthcare Conference beginning on January 12, 2015. | urologix150084_8k.htm |